VEGF<sub>121</sub>b and VEGF<sub>165</sub>b are weakly angiogenic isoforms of VEGF-A.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 320, doi. 10.1186/1476-4598-9-320
- By:
- Publication type:
- Article
Works matching IS 14764598 AND DT 2010 AND VI 9
Results: 320
1
2
PC3 prostate tumor-initiating cells with molecular profile FAM65B<sup>high</sup>/MFI2<sup>low</sup>/LEF1<sup>low</sup> increase tumor angiogenesis.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 319, doi. 10.1186/1476-4598-9-319
- By:
- Publication type:
- Article
3
Overexpression of proto-oncogene FBI-1 activates membrane type 1-matrix metalloproteinase in association with adverse outcome in ovarian cancers.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 318, doi. 10.1186/1476-4598-9-318
- By:
- Publication type:
- Article
4
Downregulation of miR-342 is associated with tamoxifen resistant breast tumors.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 317, doi. 10.1186/1476-4598-9-317
- By:
- Publication type:
- Article
5
A critical role for lymphatic endothelial heparan sulfate in lymph node metastasis.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 316, doi. 10.1186/1476-4598-9-316
- By:
- Publication type:
- Article
6
c-Jun NH2-terminal kinase-dependent upregulation of DR5 mediates cooperative induction of apoptosis by perifosine and TRAIL.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 315, doi. 10.1186/1476-4598-9-315
- By:
- Publication type:
- Article
7
The antagonism between MCT-1 and p53 affects the tumorigenic outcomes.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 311, doi. 10.1186/1476-4598-9-311
- By:
- Publication type:
- Article
8
Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 314, doi. 10.1186/1476-4598-9-314
- By:
- Publication type:
- Article
9
The ERK MAP kinase-PEA3/ETV4-MMP-1 axis is operative in oesophageal adenocarcinoma.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 313, doi. 10.1186/1476-4598-9-313
- By:
- Publication type:
- Article
10
Integrin-mediated function of Rab GTPases in cancer progression.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 312, doi. 10.1186/1476-4598-9-312
- By:
- Publication type:
- Article
11
Targeting the oncogenic protein beta-catenin to enhance chemotherapy outcome against solid human cancers.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 310, doi. 10.1186/1476-4598-9-310
- By:
- Publication type:
- Article
12
Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and clinical isolatedhuman cancer cells.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 309, doi. 10.1186/1476-4598-9-309
- By:
- Publication type:
- Article
13
Broccoli, PTEN deletion and prostate cancer: where is the link?
- Published in:
- Molecular Cancer, 2010, v. 9, p. 308, doi. 10.1186/1476-4598-9-308
- By:
- Publication type:
- Article
14
Deletion or insertion in the first immunoglobulinplexin-transcription (IPT) domain differentially regulates expression and tumorigenic activities of RON receptor Tyrosine Kinase.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 307, doi. 10.1186/1476-4598-9-307
- By:
- Publication type:
- Article
15
Serum microRNAs as non-invasive biomarkers for cancer.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 306, doi. 10.1186/1476-4598-9-306
- By:
- Publication type:
- Article
16
Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 305, doi. 10.1186/1476-4598-9-305
- By:
- Publication type:
- Article
17
Human homolog of Drosophila Hairy and enhancer of split 1, Hes1, negatively regulates δ-catenin (CTNND2) expression in cooperation with E2F1 in prostate cancer.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 304, doi. 10.1186/1476-4598-9-304
- By:
- Publication type:
- Article
18
Investigation of DNA damage response and apoptotic gene methylation pattern in sporadic breast tumors using high throughput quantitativeDNA methylation analysis technology.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 303, doi. 10.1186/1476-4598-9-303
- By:
- Publication type:
- Article
19
HTLV-I p30 inhibits multiple S phase entry checkpoints, decreases cyclin E-CDK2 interactions and delays cell cycle progression.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 302, doi. 10.1186/1476-4598-9-302
- By:
- Publication type:
- Article
20
Melanoma-associated Chondroitin Sulfate Proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanomaoutgrowth in vitro and in vivo.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 301, doi. 10.1186/1476-4598-9-301
- By:
- Publication type:
- Article
21
Epigenetic control of the basal-like gene expression profile via Interleukin-6 in breast cancer cells.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 300, doi. 10.1186/1476-4598-9-300
- By:
- Publication type:
- Article
22
Oncogenic KRAS modulates mitochondrial metabolism in human colon cancer cells by inducing HIF-1α and HIF-2α target genes.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 293, doi. 10.1186/1476-4598-9-293
- By:
- Publication type:
- Article
23
ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 291, doi. 10.1186/1476-4598-9-291
- By:
- Publication type:
- Article
24
Luciferase expression and bioluminescence does not affect tumor cell growth in vitro or in vivo.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 299, doi. 10.1186/1476-4598-9-299
- By:
- Publication type:
- Article
25
Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 296, doi. 10.1186/1476-4598-9-296
- By:
- Publication type:
- Article
26
Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 295, doi. 10.1186/1476-4598-9-295
- By:
- Publication type:
- Article
27
Role of the atypical chemoattractant receptor CRAM in regulating CCL19 induced CCR7 responses in B-cell chronic lymphocytic leukemia.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 297, doi. 10.1186/1476-4598-9-297
- By:
- Publication type:
- Article
28
The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 298, doi. 10.1186/1476-4598-9-298
- By:
- Publication type:
- Article
29
Aberrant WNT/b-catenin signaling in parathyroid carcinoma.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 294, doi. 10.1186/1476-4598-9-294
- By:
- Publication type:
- Article
30
mTOR signaling is activated by FLT3 kinase and promotes survival of FLT3-mutated acute myeloid leukemia cells.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 292, doi. 10.1186/1476-4598-9-292
- By:
- Publication type:
- Article
31
The two most common histological subtypes of malignant germ cell tumour are distinguished by global microRNA profiles, associated withdifferential transcription factor expression.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 290, doi. 10.1186/1476-4598-9-290
- By:
- Publication type:
- Article
32
Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 289, doi. 10.1186/1476-4598-9-289
- By:
- Publication type:
- Article
33
Increasing CD44+/CD24- tumor stem cells, and upregulation of COX-2 and HDAC6, as major functions of HER2 in breast tumorigenesis.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 288, doi. 10.1186/1476-4598-9-288
- By:
- Publication type:
- Article
34
Podoplanin in cancer cells is experimentally able to attenuate prolymphangiogenic and lymphogenous metastatic potentials of lungsquamoid cancer cells.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 287, doi. 10.1186/1476-4598-9-287
- By:
- Publication type:
- Article
35
ADP-ribose polymer - a novel and general biomarker of human cancers of head & neck, breast, and cervix.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 286, doi. 10.1186/1476-4598-9-286
- By:
- Publication type:
- Article
36
Cyanidin-3-Glucoside inhibits ethanol-induced invasion of breast cancer cells overexpressing ErbB2.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 285, doi. 10.1186/1476-4598-9-285
- By:
- Publication type:
- Article
37
Influence of wild-type MLL on glucocorticoid sensitivity and response to DNA-damage in pediatric acute lymphoblastic leukemia.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 284, doi. 10.1186/1476-4598-9-284
- By:
- Publication type:
- Article
38
Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 283, doi. 10.1186/1476-4598-9-283
- By:
- Publication type:
- Article
39
Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 282, doi. 10.1186/1476-4598-9-282
- By:
- Publication type:
- Article
40
Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 280, doi. 10.1186/1476-4598-9-280
- By:
- Publication type:
- Article
41
IGFBP-rP1, a potential molecule associated with colon cancer differentiation.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 281, doi. 10.1186/1476-4598-9-281
- By:
- Publication type:
- Article
42
Sp1 acetylation is associated with loss of DNA binding at promoters associated with cell cycle arrest and cell death in a colon cell line.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 275, doi. 10.1186/1476-4598-9-275
- By:
- Publication type:
- Article
43
Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 273, doi. 10.1186/1476-4598-9-273
- By:
- Publication type:
- Article
44
An essential role for Ran GTPase in epithelial ovarian cancer cell survival.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 272, doi. 10.1186/1476-4598-9-272
- By:
- Publication type:
- Article
45
FasL and FADD delivery by a glioma-specific and cell cycle-dependent HSV-1 amplicon virus enhanced apoptosis in primary human brain tumors.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 270, doi. 10.1186/1476-4598-9-270
- By:
- Publication type:
- Article
46
The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesis.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 271, doi. 10.1186/1476-4598-9-271
- By:
- Publication type:
- Article
47
Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 279, doi. 10.1186/1476-4598-9-279
- By:
- Publication type:
- Article
48
Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 277, doi. 10.1186/1476-4598-9-277
- By:
- Publication type:
- Article
49
Butyrate suppresses expression of neuropilin I in colorectal cell lines through inhibition of Sp1 transactivation.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 276, doi. 10.1186/1476-4598-9-276
- By:
- Publication type:
- Article
50
Dasatinib reduces FAK phosphorylation increasing the effects of RPI-1 inhibition in a RET/PTC1-expressing cell line.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 278, doi. 10.1186/1476-4598-9-278
- By:
- Publication type:
- Article